SAMSUNG PHARM. Co., LTD. (KRX:001360)
1,508.00
+4.00 (0.27%)
At close: Apr 16, 2025, 3:30 PM KST
SAMSUNG PHARM. Co., LTD. Statistics
Total Valuation
KRX:001360 has a market cap or net worth of KRW 141.75 billion.
Market Cap | 141.75B |
Enterprise Value | n/a |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
KRX:001360 has 94.12 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 94.12M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | -6.93% |
Owned by Insiders (%) | 0.01% |
Owned by Institutions (%) | 4.18% |
Float | 84.26M |
Valuation Ratios
The trailing PE ratio is 11.15.
PE Ratio | 11.15 |
Forward PE | n/a |
PS Ratio | 3.20 |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 184.56M |
Profits Per Employee | 52.96M |
Employee Count | 240 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.87% in the last 52 weeks. The beta is 1.19, so KRX:001360's price volatility has been higher than the market average.
Beta (5Y) | 1.19 |
52-Week Price Change | -5.87% |
50-Day Moving Average | 1,538.22 |
200-Day Moving Average | 1,587.35 |
Relative Strength Index (RSI) | 50.55 |
Average Volume (20 Days) | 274,208 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:001360 had revenue of KRW 44.29 billion and earned 12.71 billion in profits.
Revenue | 44.29B |
Gross Profit | 44.29B |
Operating Income | 14.83B |
Pretax Income | 12.71B |
Net Income | 12.71B |
EBITDA | n/a |
EBIT | 14.83B |
Earnings Per Share (EPS) | n/a |
Balance Sheet
Cash & Cash Equivalents | n/a |
Total Debt | n/a |
Net Cash | n/a |
Net Cash Per Share | n/a |
Equity (Book Value) | n/a |
Book Value Per Share | n/a |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of 33.48% and 28.70%.
Gross Margin | 100.00% |
Operating Margin | 33.48% |
Pretax Margin | 28.70% |
Profit Margin | 28.70% |
EBITDA Margin | n/a |
EBIT Margin | 33.48% |
FCF Margin | n/a |
Dividends & Yields
KRX:001360 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | 8.97% |
FCF Yield | n/a |
Stock Splits
The last stock split was on April 26, 1995. It was a forward split with a ratio of 1.1.
Last Split Date | Apr 26, 1995 |
Split Type | Forward |
Split Ratio | 1.1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |